Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2006 2
2008 1
2010 1
2011 3
2012 1
2013 3
2014 2
2015 1
2017 1
2019 2
2020 2
2021 4
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean tong xin xie (18 results)?
Targeting the Nerve-Cancer Circuit.
Ye Y, Xie T, Amit M. Ye Y, et al. Among authors: xie t. Cancer Res. 2023 Aug 1;83(15):2445-2447. doi: 10.1158/0008-5472.CAN-23-1754. Cancer Res. 2023. PMID: 37470842
β-Adrenergic signaling in skin cancer.
Batalla-Covello J, Ali S, Xie T, Amit M. Batalla-Covello J, et al. Among authors: xie t. FASEB Bioadv. 2022 Jan 6;4(4):225-234. doi: 10.1096/fba.2021-00097. eCollection 2022 Apr. FASEB Bioadv. 2022. PMID: 35415461 Free PMC article. Review.
TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma.
Shi Y, Ren X, Cao S, Chen X, Yuan B, Brasil da Costa FH, Rodriguez Rosario AE, Corona A, Michikawa C, Veeramachaneni R, Osman AA, Xie T, Wang W, Sikora AG, Myers JN, Rangel R. Shi Y, et al. Among authors: xie t. J Immunother Cancer. 2023 Aug;11(8):e006666. doi: 10.1136/jitc-2023-006666. J Immunother Cancer. 2023. PMID: 37604640 Free PMC article.
Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.
Baruch EN, Nagarajan P, Gleber-Netto FO, Rao X, Xie T, Akhter S, Adewale A, Shajedul I, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Harwood C, Leigh I, Ajami N, Futreal A, Castillo M, Gunaratne P, Goepfert RP, Khushalani N, Wang J, Watowich S, Calin GA, Migden MR, Vermeer P, D'Silva N, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo J, Myers JN, Gross ND, Amit M. Baruch EN, et al. Among authors: xie t. Res Sq [Preprint]. 2023 Jul 18:rs.3.rs-3161761. doi: 10.21203/rs.3.rs-3161761/v1. Res Sq. 2023. PMID: 37503252 Free PMC article. Preprint.
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner.
Pifer PM, Yang L, Kumar M, Xie T, Frederick M, Hefner A, Beadle B, Molkentine D, Molkentine J, Dhawan A, Abdelhakiem M, Osman AA, Leibowitz BJ, Myers JN, Pickering CR, Sandulache VC, Heymach J, Skinner HD. Pifer PM, et al. Among authors: xie t. Clin Cancer Res. 2024 Jan 5;30(1):187-197. doi: 10.1158/1078-0432.CCR-23-0964. Clin Cancer Res. 2024. PMID: 37819945 Free PMC article.
Humanized Biomimetic Nanovesicles for Neuron Targeting.
Zinger A, Cvetkovic C, Sushnitha M, Naoi T, Baudo G, Anderson M, Shetty A, Basu N, Covello J, Tasciotti E, Amit M, Xie T, Taraballi F, Krencik R. Zinger A, et al. Among authors: xie t. Adv Sci (Weinh). 2021 Oct;8(19):e2101437. doi: 10.1002/advs.202101437. Epub 2021 Aug 11. Adv Sci (Weinh). 2021. PMID: 34382379 Free PMC article.
Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.
Santi MD, Zhang M, Liu N, Viet CT, Xie T, Jensen DD, Amit M, Pan H, Ye Y. Santi MD, et al. Among authors: xie t. Pharmaceuticals (Basel). 2023 Nov 3;16(11):1558. doi: 10.3390/ph16111558. Pharmaceuticals (Basel). 2023. PMID: 38004424 Free PMC article. Review.
37 results